Status:
UNKNOWN
Magnetic Resonance Imaging in Cerebral Small Vessel Disease
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Cerebral Small Vessel Diseases
MRI
Eligibility:
All Genders
18+ years
Brief Summary
Cerebral small vessel disease (cSVD) accounts for 20% of ischemic strokes and is the most common cause of vascular cognitive impairment. Early identification of cSVD is critical for early intervention...
Detailed Description
Cerebral small vessel disease (cSVD) accounts for 20% of ischemic strokes and is the most common cause of vascular cognitive impairment. Early identification of cSVD is critical for early intervention...
Eligibility Criteria
Inclusion
- Clinical evidence of cerebral small vessel disease or MRI evidence of lacunar infarcts and white matter hyperintensity
- No disability (modified Rankin's scale \< 2)
- No dementia (MMSE \> 24 and absence of dependence in daily activities)
- Able and willing to consent
Exclusion
- Contraindications to MRI
- Standard MRI of bad quality due to movement artefacts
- Pregnant
- Unable to tolerate MRI
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05200377
Start Date
January 1 2022
End Date
December 31 2025
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, China, 100853